GenMark Diagnostics, Inc
GNMK
GNMK was delisted on the 21st of April, 2021.
86 hedge funds and large institutions have $618M invested in GenMark Diagnostics, Inc in 2017 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 30 increasing their positions, 26 reducing their positions, and 9 closing their positions.
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
15% more repeat investments, than reductions
Existing positions increased: 30 | Existing positions reduced: 26
11% more first-time investments, than exits
New positions opened: 10 | Existing positions closed: 9
7% more capital invested
Capital invested by funds: $577M → $618M (+$40.6M)
4% less funds holding
Funds holding: 90 → 86 (-4)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$35.7M |
| 2 |
GTC
Ghost Tree Capital
New York
|
+$7.82M |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$4.85M |
| 4 |
SSA
Schonfeld Strategic Advisors
New York
|
+$3.91M |
| 5 |
BG
Bellevue Group
Kuesnacht,
Switzerland
|
+$3.76M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$12.4M |
| 2 |
Adage Capital Partners
Boston,
Massachusetts
|
-$2.41M |
| 3 |
Jennison Associates
New York
|
-$1.49M |
| 4 |
AIM
Artemis Investment Management
Edinburgh,
United Kingdom
|
-$1.33M |
| 5 |
CC
Casdin Capital
New York
|
-$1.32M |
GNMK Hedge Fund Activity: Q1 2017 in Review
86 of the 4,018 institutional investors tracked by Wall St. Rank reported a position in GenMark Diagnostics, Inc (GNMK) for Q1 2017, worth a combined $618M — up 7% from $577M a quarter earlier.
Buyers outnumbered sellers: 10 funds opened new GNMK positions and 9 closed out — a net gain of 1 holder — while 30 added to existing stakes and 26 trimmed.
The largest buyer was BlackRock, adding an estimated $35.7M. The largest seller was Morgan Stanley, cutting an estimated $12.4M.
- 86 institutional investors held GenMark Diagnostics, Inc (GNMK) as of Q1 2017, down from 90 in Q4 2016.
- Funds reported $618M of GenMark Diagnostics, Inc stock for Q1 2017, up 7% quarter-over-quarter.
- 10 funds opened new GenMark Diagnostics, Inc positions in Q1 2017 and 9 closed out, a net change of +1 holder.
- The largest GenMark Diagnostics, Inc buyer in Q1 2017 was BlackRock, an estimated $35.7M added.
- The largest GenMark Diagnostics, Inc seller in Q1 2017 was Morgan Stanley, an estimated $12.4M sold.
Based on aggregated 13F filings for Q1 2017.